UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A pilot study of atorvastatin treatment in dyslipemid, non‐alcoholic fatty liver patients

Alimentary pharmacology & therapeutics, 2006-06, Vol.23 (11), p.1643-1647

2006

Volltextzugriff (PDF)

Systematic review: hepatitis‐associated aplastic anaemia – a syndrome associated with abnormal immunological function

Alimentary pharmacology & therapeutics, 2009-09, Vol.30 (5), p.436-443

2009

Volltextzugriff (PDF)

Empirical rescue therapy after Helicobacter pylori treatment failure: a 10‐year single‐centre study of 500 patients

Alimentary pharmacology & therapeutics, 2008-02, Vol.27 (4), p.346-354

2008

Volltextzugriff (PDF)

Third‐line rescue therapy with levofloxacin is more effective than rifabutin rescue regimen after two Helicobacter pylori treatment failures

Alimentary pharmacology & therapeutics, 2006-11, Vol.24 (10), p.1469-1474

2006

Volltextzugriff (PDF)

Commentary: ursodeoxycholic acid as chemoprevention in inflammatory bowel disease and primary sclerosing cholangitis

Alimentary pharmacology & therapeutics, 2012-04, Vol.35 (7), p.846-846

2012

Volltextzugriff (PDF)

Transient elastography to assess hepatic fibrosis in primary biliary cirrhosis

Alimentary pharmacology & therapeutics, 2008-03, Vol.27 (5), p.441-447

2008

Volltextzugriff (PDF)

Review article: pharmacological therapy for hepatocellular carcinoma with sorafenib and other oral agents

Alimentary pharmacology & therapeutics, 2008-12, Vol.28 (11‐12), p.1269-1277

2008

Volltextzugriff (PDF)

Transient elastography: a valid alternative to biopsy in patients with chronic liver disease

Alimentary pharmacology & therapeutics, 2006-08, Vol.24 (3), p.513-518

2006

Volltextzugriff (PDF)

Letter: impact of mild alcohol consumption in chronic hepatitis C treatment

Alimentary pharmacology & therapeutics, 2013-06, Vol.37 (11), p.1118-1119

2013

Volltextzugriff (PDF)

Systematic review: regression of lymphoproliferative disorders after treatment for hepatitis C infection

Alimentary pharmacology & therapeutics, 2005-03, Vol.21 (6), p.653-662

2005

Volltextzugriff (PDF)

Mycophenolate mofetil for patients with autoimmune hepatitis and overlap syndromes

Alimentary pharmacology & therapeutics, 2011-09, Vol.34 (6), p.682-684

2011

Volltextzugriff (PDF)

Letter: acute hepatitis B - to treat or not to treat?

Alimentary pharmacology & therapeutics, 2012-07, Vol.36 (1), p.76-77

2012

Volltextzugriff (PDF)

Therapeutic modalities in hepatitis C: challenges and development

Journal of viral hepatitis, 2005-01, Vol.12 (1), p.10-19

Moreno-Otero, R.

2005

Volltextzugriff (PDF)

Peripheral blood monocyte subsets predict antiviral response in chronic hepatitis C

Alimentary pharmacology & therapeutics, 2011-10, Vol.34 (8), p.960-971

2011

Volltextzugriff (PDF)

Helicobacter pylori first-line treatment and rescue option containing levofloxacin in patients allergic to penicillin

Digestive and liver disease, 2010-04, Vol.42 (4), p.287-290

2010

Volltextzugriff (PDF)

Genetic Variants of Interferon-Stimulated Genes and IL-28B as Host Prognostic Factors of Response to Combination Treatment for Chronic Hepatitis C

Clinical pharmacology and therapeutics, 2011-11, Vol.90 (5), p.712-721

2011

Volltextzugriff (PDF)

Antioxidants for liver disease

Alimentary pharmacology & therapeutics, 2010-11, Vol.32 (10), p.1292-1293

2010

Volltextzugriff (PDF)

Liver fibrosis assessment by transient elastography in hepatitis C patients with normal alanine aminotransferase

Gut, 2006-07, Vol.55 (7), p.1055-1056

2006

Volltextzugriff (PDF)

Polymorphisms in histone deacetylases improve the predictive value of IL-28B for chronic hepatitis C therapy

Genes and immunity, 2013-07, Vol.14 (5), p.317-324

2013

Volltextzugriff (PDF)

Azathioprine plus ribavirin treatment and pancytopenia

Alimentary pharmacology & therapeutics, 2009-11, Vol.30 (9), p.962-963

2009

Volltextzugriff (PDF)

Immunopathogenetic and therapeutic aspects of autoimmune hepatitis

Alimentary pharmacology & therapeutics, 2003-01, Vol.17 (1), p.1-16

2003

Volltextzugriff (PDF)

Review article: angiogenesis soluble factors as liver disease markers

Alimentary pharmacology & therapeutics, 2005-07, Vol.22 (1), p.23-30

2005

Volltextzugriff (PDF)

ANG2/ANG1 Ratio as Non-Invasive Biomarker of Cirrhosis in Patients with Chronic Hepatitis C

Journal of hepatology, 2016, Vol.64 (2), p.S412-S412

2016

Volltextzugriff (PDF)

Evaluation of liver fibrosis by transient elastography (Fibroscan®) in patients with inflammatory bowel disease treated with methotrexate: a multicentric trial

Scandinavian journal of gastroenterology, 2012-05, Vol.47 (5), p.575-579

2012

Volltextzugriff (PDF)

Thyroid autoimmune disorders in patients with chronic hepatitis C before and during interferon-α therapy

Clinical endocrinology (Oxford), 1996-06, Vol.44 (6), p.635-642

1996

Volltextzugriff (PDF)

1 – 25 von 327

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(307)
Mit Volltextzugriff
(241)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(180)
Life Sciences & Biomedicine
(120)
Science & Technology
(120)
Gastroenterology & Hepatology
(91)
Male
(90)
Middle Aged
(87)
Female
(86)
Biological And Medical Sciences
(83)
Adult
(82)
Medical Sciences
(82)
Pharmacology & Pharmacy
(44)
Aged
(42)
Infectious Diseases
(40)
Gastroenterology. Liver. Pancreas. Abdomen
(37)
Gastroenterology And Hepatology
(35)
Pharmacology. Drug Treatments
(34)
Viral Diseases
(29)
Antiviral Agents - Therapeutic Use
(28)
Human Viral Diseases
(27)
Interferon-Alpha - Therapeutic Use
(26)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A pilot study of atorvastatin treatment in dyslipemid, non‐alcoholic fatty liver patients

Systematic review: hepatitis‐associated aplastic anaemia – a syndrome associated with abnormal immunological function

Empirical rescue therapy after Helicobacter pylori treatment failure: a 10‐year single‐centre study of 500 patients

Third‐line rescue therapy with levofloxacin is more effective than rifabutin rescue regimen after two Helicobacter pylori treatment failures

Commentary: ursodeoxycholic acid as chemoprevention in inflammatory bowel disease and primary sclerosing cholangitis

Transient elastography to assess hepatic fibrosis in primary biliary cirrhosis

Review article: pharmacological therapy for hepatocellular carcinoma with sorafenib and other oral agents

Transient elastography: a valid alternative to biopsy in patients with chronic liver disease

Letter: impact of mild alcohol consumption in chronic hepatitis C treatment

Systematic review: regression of lymphoproliferative disorders after treatment for hepatitis C infection

Mycophenolate mofetil for patients with autoimmune hepatitis and overlap syndromes

Letter: acute hepatitis B - to treat or not to treat?

Therapeutic modalities in hepatitis C: challenges and development

Peripheral blood monocyte subsets predict antiviral response in chronic hepatitis C

Helicobacter pylori first-line treatment and rescue option containing levofloxacin in patients allergic to penicillin

Genetic Variants of Interferon-Stimulated Genes and IL-28B as Host Prognostic Factors of Response to Combination Treatment for Chronic Hepatitis C

Antioxidants for liver disease

Liver fibrosis assessment by transient elastography in hepatitis C patients with normal alanine aminotransferase

Polymorphisms in histone deacetylases improve the predictive value of IL-28B for chronic hepatitis C therapy

Azathioprine plus ribavirin treatment and pancytopenia

Immunopathogenetic and therapeutic aspects of autoimmune hepatitis

Review article: angiogenesis soluble factors as liver disease markers

ANG2/ANG1 Ratio as Non-Invasive Biomarker of Cirrhosis in Patients with Chronic Hepatitis C

Evaluation of liver fibrosis by transient elastography (Fibroscan®) in patients with inflammatory bowel disease treated with methotrexate: a multicentric trial

Thyroid autoimmune disorders in patients with chronic hepatitis C before and during interferon-α therapy

Suchergebnisse filtern